Jim Cramer can’t help but wonder if this old dog of a stock has learned new tricks.» Read More
"There's a lot of hope built into the market," said one strategist. "In large part, reality still has not been realized."
When a company reports a blowout quarter, investors often see a tradable short squeeze develop as the bears rush to cover positions to avoid big losses. TheStreet.com reports.
Stocks remain the best investment and stand to post "respectable" gains, says Omega Advisors CEO Leon Cooperman, who shares his top picks.
"I'm going to sell this rally with two hands, two feet and all 10 toes," said Lawrence McDonald, a trader and political risk consultant, in a tweet after the "fiscal cliff" deal was approved Tuesday night.
A leading indicator for the next few months lies in this key component, says Joe Terranova of Virtus Investment Partners.
CNBC's Eamon Javers reports the President is putting pressure on the House to pass a vote on Hurricane Sandy aid. And a look at the best bank trades now, with David Katz, Matrix Asset Advisors; and Paul Miller, FBR Capital Markets.
CNBC's Diana Olick reports housing stocks are up on two big tax breaks in the "fiscal cliff" deal passed last night in the House.
CNBC's Jackie DeAngelis explains how the "fiscal cliff" deal will impact the health care sector in the long-term. And, Jonathan Bush, Athenahealth chairman, CEO & president, provides perspective on health care reform and the 'cliff' deal.
Cramer shares six stocks to watch, and reveals them in under 60 seconds.
The deal reached last night does nothing for the spending cuts side of the equation. The only good news for spending hawks: the next debate will be squarely on spending.
Hope springs eternal among most stock strategists and Jeremy Zirin, chief equity strategist at UBS Wealth Management, is no exception. Zirin expects moderate gains in stocks this year.
Jim Cramer explains which retail stocks investors should be watching today, including Target, Ross Stores, Urban Outfitters, and Skullcandy.
CNBC's Jim Cramer tells investors how they should approach the stock market this year, now that there's a "fiscal cliff" deal.
TheStreet.com offers up 13 biotech predictions for 2013.
Some of the names on the move ahead of the open.
U.S. stocks are set to move higher short term on a temporary fix to the "fiscal cliff."
Fast-money traders went shopping in Gap on Monday morning.
Markets are relieved that the U.S. Congress has approved a deal to avert a "fiscal cliff", but analysts warn that investors now face a rocky two months ahead as negotiations over the debt ceiling begin.
The "Mad Money" host outlines how investors can avoid some of the most common and money-losing mistakes.
A few sectors show relative strength for 2013, JPMorgan Chief U.S. Equity Strategist Thomas Lee says.
Get the best of CNBC in your inbox